BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25660725)

  • 1. Monogenic neurological disorders of sphingolipid metabolism.
    Sabourdy F; Astudillo L; Colacios C; Dubot P; Mrad M; Ségui B; Andrieu-Abadie N; Levade T
    Biochim Biophys Acta; 2015 Aug; 1851(8):1040-51. PubMed ID: 25660725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sphingolipid salvage pathway in ceramide metabolism and signaling.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of sphingolipid hydrolases and sphingolipid storage diseases.
    Schuchman EH; Simonaro CM
    Handb Exp Pharmacol; 2013; (215):3-32. PubMed ID: 23579447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders.
    Sural-Fehr T; Bongarzone ER
    J Neurosci Res; 2016 Nov; 94(11):1042-8. PubMed ID: 27638590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.
    Quinville BM; Deschenes NM; Ryckman AE; Walia JS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.
    Haughey NJ; Bandaru VV; Bae M; Mattson MP
    Biochim Biophys Acta; 2010 Aug; 1801(8):878-86. PubMed ID: 20452460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipids in mitochondria.
    Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
    Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipids and lysosomal pathologies.
    Schulze H; Sandhoff K
    Biochim Biophys Acta; 2014 May; 1841(5):799-810. PubMed ID: 24184515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cholesterol and sphingolipids in brain development and neurological diseases.
    Hussain G; Wang J; Rasul A; Anwar H; Imran A; Qasim M; Zafar S; Kamran SKS; Razzaq A; Aziz N; Ahmad W; Shabbir A; Iqbal J; Baig SM; Sun T
    Lipids Health Dis; 2019 Jan; 18(1):26. PubMed ID: 30683111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
    Sandhoff K
    Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of altered sphingolipid acyl chain length on various disease models.
    Park WJ; Park JW
    Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
    Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
    J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction.
    Posse de Chaves E; Sipione S
    FEBS Lett; 2010 May; 584(9):1748-59. PubMed ID: 20006608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism and function of sphingolipids and glycosphingolipids.
    Lahiri S; Futerman AH
    Cell Mol Life Sci; 2007 Sep; 64(17):2270-84. PubMed ID: 17558466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingoid bases and their involvement in neurodegenerative diseases.
    Goins L; Spassieva S
    Adv Biol Regul; 2018 Dec; 70():65-73. PubMed ID: 30377075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expanding role of sphingolipids in lipid droplet biogenesis.
    Deevska GM; Nikolova-Karakashian MN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt B):1155-1165. PubMed ID: 28743537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
    Park JW; Park WJ; Futerman AH
    Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.